Drug Shortage Report for CUPRIMINE
| Report ID | 186886 |
| Drug Identification Number | 00016055 |
| Brand name | CUPRIMINE |
| Common or Proper name | CUPRIMINE |
| Company Name | BAUSCH HEALTH, CANADA INC. |
| Market Status | MARKETED |
| Active Ingredient(s) | PENICILLAMINE |
| Strength(s) | 250MG |
| Dosage form(s) | CAPSULE |
| Route of administration | ORAL ORAL |
| Packaging size | 250 |
| ATC code | M01CC |
| ATC description | SPECIFIC ANTIRHEUMATIC AGENTS |
| Reason for shortage | Other (Please describe in comments) |
| Anticipated start date | 2023-04-03 |
| Actual start date | |
| Estimated end date | 2023-04-28 |
| Actual end date | 2022-03-21 |
| Shortage status | Avoided shortage |
| Updated date | 2023-03-23 |
| Company comments | Requirements related to complying with GUI-0069 |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 2150 BOUL. ST-ELZEAR OUEST LAVAL, QUEBEC CANADA H7L 4A8 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v3 | 2023-03-23 | English | Compare |
| v2 | 2023-03-13 | French | Compare |
| v1 | 2023-03-13 | English | Compare |
Showing 1 to 3 of 3